NCT07310108 (FUN) is a NA clinical trial of Cordyceps Militaris in Aerobic, sponsored by Lindenwood University.

Who is sponsoring NCT07310108?

NCT07310108 is sponsored by Lindenwood University.

What drugs are being tested in NCT07310108?

Interventions in NCT07310108: Cordyceps Militaris, Placebo.

What condition does NCT07310108 study?

NCT07310108 studies Aerobic, Exercise.

Is NCT07310108 still recruiting?

NCT07310108 is currently completed. Last updated 30 December 2025.

Last reviewed 2025-12-30 · How we verify

NCT07310108: FUN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Cordyceps Militaris M2-116-04 for Its Potential Sport and Exercise Nutrition Applications in Healthy Active Adults

Completed NA Last updated 30 December 2025

What this trial tests

NA trial testing Cordyceps Militaris in Aerobic in 32 participants. Completed in 7 November 2025.

Timeline

21 May 2025

Primary endpoint
7 November 2025

7 November 2025

Quick facts

Lead sponsor	Lindenwood University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	32
Start date	21 May 2025
Primary completion	7 November 2025
Estimated completion	7 November 2025
Sites	1 location across United States

Drugs / interventions tested

Cordyceps Militaris
Placebo

Conditions studied

Aerobic — all drugs for Aerobic →
Exercise — all drugs for Exercise →

Sponsor

Lindenwood University

Who can join

Adults 20 to 50, any sex, with Aerobic or Exercise. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to examine the effects of supplementation with Cordyceps militaris MS-116-04 on exercise performance, endurance, cardiovascular fitness, gastrointestinal wellness, mood, and recovery compared to a placebo in healthy active adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Lindenwood University trials

Trials by the same sponsor.

NCT07387991 — Evaluating the Ability of a Multi-Strain Postbiotic to Impact Inflammation, Immune Components, Gastrointestinal Symptoms · NA · not yet recruiting
NCT07388264 — Impact of Weizmannia (Bacillus) Coagulans JBI-YZ6.3 on Gut Health and Fecal Microbiome Changes · NA · recruiting
NCT06672952 — Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Othe · NA · recruiting
NCT07502924 — Dose-Response Impact of Geranylgeraniol (GG) Supplementation on Muscle Health · NA · recruiting
NCT06795425 — A Randomized, Double-Blind Study to Assess the Effect of a Postbiotic on Oxidative Stress and Exercise Performance · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07310108 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lindenwood University
Last refreshed: 30 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07310108.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing